SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (1031)8/18/1998 12:06:00 PM
From: TokyoMex  Read Replies (1) | Respond to of 1510
 
R O F L M A O ,,,,,,

IMNR moves in September, and why? it be because of BTAlex Brown, or because of the data presented September 27, or because they may file for early approval in october based on data presented Sept. 27...or because psoriasis results are good and will be released in September...or Paine Webber may come with a buy rec...

All of above ,,

;-)



To: TokyoMex who wrote (1031)8/18/1998 2:41:00 PM
From: John S. Baker  Respond to of 1510
 
Hiya! Welcome to the IMNR thread.


I have been long in IMNR for some time ... primarily fundamental reasons ... looking for "cheap" buying opportunity to get a "trading stash". It's close, but probably not today.


There will be those who say that IMNR is not a trading stock. 'Tis true that this is *not* a single-product company.


JSb.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News